Shun-Xian Zhang

Prof. Dr. Shun-Xian Zhang

China CDC
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2016 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
SZShun-Xian Zhang
Shun-Xian Zhang
YZYong-Ming Zhou
Yong-Ming Zhou
WXWen Xu
Wen Xu
LTLi-Guang Tian
Li-Guang Tian
JCJia xu chen
Jia xu chen
XZXiao-Nong Zhou
Xiao-Nong Zhou
Acute diarrhea is a global health problem, resulting in high morbidity and mortality in children. It has been suggested that enteric pathogen co-infections play an important role in gastroenteritis, but most research efforts have only focused on a small range of species belonging to a few pathogen groups. This study aimed to assess the impact of co-infections with a broad range of enteric pathogens on children aged below five years who suffer from acute diarrhea in southwest China. A total of 1020 subjects (850 diarrhea cases and 170 healthy controls) were selected from four sentinel hospitals in Kunming, Yunnan province, southwest China, from June 2014 to July 2015. Stool specimens were collected to detect five virus (rotavirus group A, RVA; norovirus, NoV; Sapovirus, SaV; astrovirus, As; and adenovirus, Ad), seven bacterial (diarrheagenic Escherichia coli, DEC; non-typhoidal Salmonella, NTS; Shigella spp.; Vibrio cholera; Vibrio parahaemolyticus; Aeromonas spp.; and Plesiomonas spp.), and three protozoan (Cryptosporidium spp., Giardia lamblia, and Blastocystis hominis, B. hominis) species using standard microbiologic and molecular methods. Data were analyzed using the partial least square regression technique and chi-square test. At least one enteric pathogen was detected in 46.7 % (n = 397) of acute gastroenteritis cases and 13.5 % (n = 23) of healthy controls (χ2 = 64.4, P < 0.05). Single infection with RVA was associated with acute diarrhea (26.5 % vs. 5.8 %, P < 0.05). The prevalence of a single infection with B. hominis in diarrhea cases was higher than in healthy controls (3.1 % vs. 0.5 %, OR = 4.7, 95 % CI: 1.01–112.0). Single infection with NoV GII was not associated with diarrhea (4.4 % vs. 3.5 %, OR = 1.2, 95 % CI: 0.5–3.3). Single infections with bacterial species were not observed. The prevalence of co-infections with two enteric pathogens in diarrhea cases was higher than in asymptomatic children (20.1 % vs. 5.3 %, P < 0.05). RVA-NoV GII was the most common co-infection in symptomatic children (4.4 %), with it aggravating the severity of diarrhea. Although it is clear that RVA has an overwhelming impact on diarrhea illnesses in children, co-infection with other enteric pathogens appears to also aggravate diarrhea severity. These findings should serve as evidence for public health services when planning and developing intervention programs.

16 August 2019 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
SZShun-Xian Zhang
Shun-Xian Zhang
WXWanfu Xu
Wanfu Xu
HWHongli Wang
Hongli Wang
MCMeiwan Cao
Meiwan Cao
MLMusheng Li
Musheng Li
LGLanlan Geng
Lanlan Geng
Objective: Inflammatory bowel disease (IBD) is a disorder intestinal inflammation and impaired barrier function, associated with increased epithelial expression of monocarboxylate transporter 4 (MCT4). However, the specific non‐metabolic function and clinical relevance of MCT4 in IBD remain to be fully elucidated.Methods: Lentivirus‐mediated overexpression of MCT4 was used to assess the role of MCT4 in transcriptionally regulating ZO‐1 and IL‐6 expression by luciferase assays, WB and ChIP. IP was used to analyse the effect of MCT4 on the interaction NF‐κB‐CBP or CREB‐CBP, and these MCT4‐mediated effects were confirmed in vivo assay.Results: We showed that ectopic expression of MCT4 inhibited ZO‐1 expression, while increased pro‐inflammatory factors expression, leading to destroy intestinal epithelial barrier function in vitro and in vivo. Mechanistically, MCT4 contributed NF‐κB p65 nuclear translocation and increased the binding of NF‐κB p65 to the promoter of IL‐6, which is attributed to MCT4 enhanced NF‐κB‐CBP interaction and dissolved CREB‐CBP complex, resulting in reduction of CREB activity and CREB‐mediated ZO‐1 expression. In addition, treatment of experimental colitis with MCT4 inhibitor α‐cyano‐4‐hydroxycinnamate (CHC) ameliorated mucosal intestinal barrier function, which was due to attenuation of pro‐inflammation factors expression and enhancement of ZO‐1 expression.Conclusion: These findings suggested a novel role of MCT4 in controlling development of IBD and provided evidence for potential targets of IBD.

15 October 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YLYujuan Liu
Yujuan Liu
WRWeifang Ren
Weifang Ren
SWShuying Wang
Shuying Wang
MXMinmin Xiang
Minmin Xiang
SZShun-Xian Zhang
Shun-Xian Zhang
FZFeng Zhang
Feng Zhang
Background: Anemia represents a significant global health issue affecting numerous children and women, characterized by diminished hemoglobin levels that may impede cognitive and developmental progress. Although commonly attributed to iron deficiency, the etiology of anemia in this demographic is multifaceted, encompassing nutritional, genetic, and infectious contributors. Nonetheless, there is a lack of high-quality data on anemia prevalence and causes analysis among children under 5 years. The aim of this study was to provide a comprehensive global assessment of the burden of anemia and its causes among children under 5 years, using data from the Global Burden of Disease Study 2019.Methods: This investigation utilized data from the Global Burden of Disease Study (GBD) 2019 to assess the prevalence and years lived with disability (YLD) attributable to anemia in children under five from 1990 to 2019. Analyses were conducted to delineate age-specific YLD, prevalence rates, and etiological factors, with stratification by gender and Socio-Demographic Index (SDI).Results: In 2019, anemia imposed a substantial global burden on children under five, with a reported YLD of 1,252.88 (95% UI: 831.62–1,831.34) per 100,000 population. The prevalence of moderate anemia was highest at 985.46 (95% UI: 646.24–1,450.49) per 100,000, surpassing both severe anemia at 197.82 (95% UI: 132.53–277.80) per 100,000 and mild anemia at 69.59 (95% UI: 24.62–152.53) per 100,000. Globally, the total prevalence was 39,517.75 (95% UI: 38,784.81 - 40,239.62) cases per 100,000 population. Notably, disparities were evident between genders, with males demonstrating higher YLD and prevalence rates than females. Iron deficiency emerged as the leading cause globally, with significant contributions from hemoglobinopathies and other nutritional deficiencies. Regions with a low Socio-Demographic Index, particularly sub-Saharan Africa and South Asia, exhibited the most pronounced burdens. Despite a declining trend over three decades, persistent regional and gender-based disparities highlight the necessity for continuous and focused public health interventions.Conclusion: The burden of anemia among children under five continues to be considerable, marked by stark regional and socioeconomic disparities. These findings underscore the urgent need for advanced nutritional and healthcare strategies tailored to alleviate anemia in this vulnerable population, with a particular emphasis on regions exhibiting low SDIs. The sustained prevalence of high anemia rates in these areas underscores the imperative for persistent, localized intervention efforts.

7 May 2018 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
SZShun-Xian Zhang
Shun-Xian Zhang
YZYong-Ming Zhou
Yong-Ming Zhou
LTLi-Guang Tian
Li-Guang Tian
JCJia xu chen
Jia xu chen
RTRita Tinoco Torres
Rita Tinoco Torres
WHWei Hu
Wei Hu
Bacterial diarrhea is one of the most common causes for medical consultations, mortality and morbidity in the world. Diarrheagenic Escherichia coli (DEC) and non-typhoidal Salmonella (NTS) are major intestinal pathogens in developing countries, and the indiscriminate use of antibiotics has greatly contributed to resistant strains. Hence, the aim of the present study is to identify the antimicrobial resistance patterns and the molecular characteristics of DEC and NTS in southwest, China. 1121 diarrheal patients and 319 non-diarrheal subjects across all age groups were recruited from four sentinel hospitals from June 2014 to July 2015 in Kunming City, Yunnan Province. Each stool specimen was collected to detect DEC and NTS with standard microbiological and molecular methods. Antimicrobial resistance testing was performed with the Kirby-Bauer disk diffusion method, and the standards for antimicrobial susceptibility testing complied with the Clinical and Laboratory Standards Institute (CLSI). Molecular characterization of strains was carried out using pulsed-field gel electrophoresis (PFGE). A structured questionnaire was used to record basic epidemiological data (e.g. sex, age, residence, season, etc.). Data were analyzed using Chi-square or Fisher’s exact test. DEC was detected in 127 (11.33%) diarrhea cases and 9 (2.82%) non-diarrheal cases (χ2 = 20.69, P < 0.001, OR = 4.36, 95% CI: 2.19–8.65), and the prevalence of NTS isolated from diarrhea cases was higher than that of non-diarrheal cases across all age groups (n = 42, 3.75%, n = 1, 0.31%, χ2 = 10.10, P = 0.002, OR = 12.38, 95% CI: 1.70–90.29). The rates of resistance to ten antibiotics of DEC and NTS showed significant differences (χ 2 = 386.77, P < 0.001; χ2 = 191.16, P < 0.001). The rates of resistance to Amoxicillin and Clavulafiate (AMC), Cephalothin (CEP), Gentamicin (GEN) and Sulfamethoxazole-Trimethoprim (SXT) of DEC isolated from diarrhea cases were higher than those of NTS isolated from diarrhea patients (37.01% vs 14.29%, χ2 = 7.57, P = 0.006; 29.92% vs 11.90%, χ2 = 5.40, P = 0.02; 37.01% vs 11.90%, χ2 = 5.80, P = 0.016; 62.20% vs 26.19%, χ2 = 16.44, P < 0.001; respectively). Ciprofloxacin (CIP) was the most sensitive antibiotic for DEC and NTS strains isolated from diarrhea cases. Resistance rates of DEC isolates from cases and controls to more than three kinds antimicrobials (multidrug resistance, MDR) showed no significant differences (81.10% vs 88.89%, P = 0.33). Pulsotype patterns of DEC strains were highly diverse; however, the pulsotype pattern of NTS strains was closely related to the serotype. The pattern of S. enteritidis was highly similar, but the S. enterica Typhimurium strain was discrete. Antibiotic resistance of Enterobacteriaceae is of great concern. The societal effects of antibiotic use justify strict monitoring to combat increases in antimicrobial resistance. Molecular epidemiology and systematic epidemiological investigation can provide accurate evidence for tracking the infection source.

4 July 2025 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
YZYun-Fei Zhang
Yun-Fei Zhang
SLShi-Zhu Li
Shi-Zhu Li
SWShi-Wen Wang
Shi-Wen Wang
DMDi Mu
Di Mu
XCXi Chen
Xi Chen
SZShun-Xian Zhang
Shun-Xian Zhang
Background: Zoonotic diseases remain a significant public health challenge in China. This study examines the temporal trends, disease burden, and demographic patterns of major zoonoses from 2010 to 2023. Methods: This study analyzed data from China’s National Notifiable Infectious Disease Reporting System (NNIDRS, 2010–2023) on nine major zoonoses, including echinococcosis, brucellosis, leptospirosis, anthrax, leishmaniasis, encephalitis (Japanese encephalitis), hemorrhagic fever, rabies, and schistosomiasis. Joinpoint regression was applied to assess annual trends in incidence rates, while autoregressive integrated moving average (ARIMA) and exponential smoothing models were used to forecast incidence trends from 2024 to 2035. To assess the performance of the Global Burden of Disease (GBD) 2021 model in China, disease-specific multipliers—defined as the ratio of GBD estimates to national surveillance data—along with their corresponding 95% confidence intervals (CIs) were calculated to quantify discrepancies and evaluate the consistency between modeled estimates and empirical observations. Results: From 2010 to 2023, the incidence rates of leptospirosis [average annual percent change (AAPC) = − 5.527%, 95% CI: − 11.054, − 0.485], encephalitis (AAPC = − 16.934%, 95% CI: − 23.690, − 11.245), hemorrhagic fever (AAPC = − 5.384%, 95% CI: − 7.754, − 2.924), rabies (AAPC = − 20.428%, 95% CI: − 21.076, − 19.841), and schistosomiasis (AAPC = − 28.378%, 95% CI: − 40.688, − 15.656) showed a declining trend in China. In contrast, brucellosis exhibited a modest but statistically significant increase (AAPC = 0.151%, 95% CI: 0.031, 0.272). For most diseases, incidence rates were consistently higher in males than females. Children aged 0–5 years accounted for a substantial proportion of encephalitis and leishmaniasis cases, while adults aged 14–65 years represented the primary affected group across the majority of diseases. Occupationally, farmers and herders were the most affected populations. Compared to national surveillance data, the GBD 2021 model substantially overestimated the burden of zoonotic diseases in China, particularly for echinococcosis (by 3.611–7.409 times) and leishmaniasis (by 3.054–10.500 times). Conclusion: The study revealed significant decline in several major zoonoses in China, while brucellosis showed a continued upward trend. These findings highlight the urgent need for a One Health-based prevention and control system to interrupt cross-species transmission and reduce long-term public health risks.

2 October 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ETEn-Li Tan
En-Li Tan
YQYu Qin
Yu Qin
JYJian Yang
Jian Yang
XLXiao-Jie Li
Xiao-Jie Li
TLTian-Qi Liu
Tian-Qi Liu
SZShun-Xian Zhang
Shun-Xian Zhang
Drug-resistant tuberculosis (TB) remains a major global health threat, reflecting disparities in healthcare capacity, access, and socioeconomic development. Previous research often lacks geographic breadth. This study provides a comprehensive assessment of the global, regional, and national burden of Multidrug-resistant TB without extensive drug resistance (MDR-TB) and extensively drug-resistant TB(XDR-TB) from in Global Burden of Disease Study (GBD) 2021 Study 1990 to 2021, with a focus on distributional inequities. The findings aim to guide resource prioritization, inform targeted interventions, and reduce the burden in high-risk populations. We systematically assessed the global, regional, and national burden of MDR-TB and XDR-TB, along with their change trends from 1990 to 2021, using data from the GBD 2021 database. The indicators included age-standardized incidence rate (ASIR), prevalence rate (ASPR), mortality rate (ASMR), and disability-adjusted life-years rate (ASDR). ASDR was analyzed in conjunction with the sociodemographic index (SDI) for a comprehensive assessment. Health inequalities were quantified using the slope index of inequality (SII) and concentration index (CCI). Frontier analysis estimated the achievable outcomes across different development levels, while decomposition analysis identified the key factors driving changes in disease burden. In 2021, the global ASIR of MDR-TB was 5.42 per 100,000 population [95% uncertainty interval(UI): 3.17, 9.34]), and the ASIR of XDR-TB was 0.29 per 100,000 population (95% UI: 0.21, 0.42). From 1990 to 2021, the ASIR of MDR-TB [AAPC = 0.14%, 95% confidence interval (CI): 0.13, 0.14] and XDR-TB (AAPC = 0.01%, 95% CI: 0.01, 0.02) both showed an increasing trend. The ASIR and ASMR of MDR-TB increased in low and low-middle SDI regions. Similarly, the ASIR and ASMR of XDR-TB increased in all five SDI regions. The ASIR of MDR-TB increased in 155 countries, with the largest increase observed in Somalia (AAPC = 1.79%, 95% CI: 1.67, 1.92). The ASIR of XDR-TB increased in all countries. From 1990 to 2021, both absolute and relative health inequalities in the ASDR of MDR-TB and XDR-TB have grown. In addition, the ASIR and incidence of MDR-TB and XDR-TB are negatively correlated with SDI. The burden of MDR-TB/XIDR-TB is projected to increase, with persistent disparities concentrated in low-SDI settings. Targeted public health strategies—including improved resource allocation, infrastructure development, and community health education—are essential to reduce inequities. Strengthening these efforts may enhance global TB control and advance progress toward health equity.